Early Recognition of Drug-Induced Febrile Neutropenia Leads to an Improved Outcome in the Trauma Intensive Care Unit: A Case Report

Bisman J.K. Khurana; Amarjyoti Hazarika; Kajal Jain

doi:10.1055/s-0044-1789205

Journal of Neuroanaesthesiology and Critical Care, Table of Contents

CC BY 4.0 · J Neuroanaesth Crit Care 2024; 11(03): 200-202
DOI: 10.1055/s-0044-1789205

Case Report

Early Recognition of Drug-Induced Febrile Neutropenia Leads to an Improved Outcome in the Trauma Intensive Care Unit: A Case Report

Bisman J.K. Khurana

¹Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Amarjyoti Hazarika

¹Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Kajal Jain

¹Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India

› Author Affiliations

Abstract

Traumatic brain injury necessitates the use of antiepileptics for seizure prophylaxis, which are associated with multiple side effects including neutropenia, which may be dose dependent or idiosyncratic. We report the case of a young male with traumatic brain injury who developed febrile neutropenia, likely secondary to antiepileptic use. Early recognition and stopping of the drugs with use of granulocyte colony-stimulating factor led to the successful management of the patient.

Keywords

febrile neutropenia - neurointensive care settings - traumatic brain injury

Full Text

References

References
1 Tahmasebivand M, Soltani F, Kouti L. et al. Frequency and risk factors of polypharmacy and drug interactions among patients in general intensive care unit of Golestan Hospital, Ahvaz, southwest of Iran. AIMS Med Sci 2020; 7: 69-78
2 Stephens RS. Neutropenic fever in the intensive care unit. In: Nates JL, Price KJ. eds. Oncologic Critical Care. Cham:: Springer International Publishing;; 2020: 1297-1311
3 Sereeaphinan C, Kanchanasuwan S, Julamanee J. Mortality-associated clinical risk factors in patients with febrile neutropenia: a retrospective study. IJID Reg 2021; 1: 5-11
4 Schnell D, Azoulay E, Benoit D. et al. Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Ann Intensive Care 2016; 6 (01) 90
5 Andrès E, Maloisel F, Zimmer J. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis. Br J Haematol 2010; 150 (01) 3-8
6 Mhaskar R, Clark OA, Lyman G, Engel Ayer Botrel T, Morganti Paladini L, Djulbegovic B. Colony-stimulating factors for chemotherapy-induced febrile neutropenia. Cochrane Database Syst Rev 2014; 2014 (10) CD003039